D-132-2013 Class II Terminated
FDA drug recall D-132-2013 was initiated by West-Ward Pharmaceutical Corp. on Nov 30, 2012 and is designated Class II. Reason for recall: Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets. The recall status is terminated (terminated Jul 9, 2014). Affected quantity: 43,478 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 30, 2013
- Initiation Date
- Nov 30, 2012
- Termination Date
- Jul 9, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 43,478 bottles
Product description
Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1264-01) and b) 1000-count tablets per bottle (NDC 0143-1264-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.
Reason for recall
Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot #: 69392A, 69393A, 69394A, 69395A, 69396A, 69397A , Exp 09/15; 69495A, 69496A, 69497A, 69498A, 69524A, 69525A, Exp 10/15
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-132-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026